SignatureFD’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-163
| Closed | -$2.85K | – | 3152 |
|
|
2024
Q1 | $2.85K | Buy |
+163
| New | +$2.85K | ﹤0.01% | 2697 |
|
|
2023
Q4 | – | Sell |
-978
| Closed | -$10.9K | – | 3161 |
|
|
2023
Q3 | $10.9K | Buy |
978
+748
| +325% | +$8.36K | ﹤0.01% | 2160 |
|
|
2023
Q2 | $4.92K | Buy |
230
+192
| +505% | +$4.11K | ﹤0.01% | 2518 |
|
|
2023
Q1 | $1.54K | Sell |
38
-60
| -61% | -$2.43K | ﹤0.01% | 2875 |
|
|
2022
Q4 | $4.56K | Sell |
98
-93
| -49% | -$4.33K | ﹤0.01% | 2513 |
|
|
2022
Q3 | $10K | Buy |
191
+25
| +15% | +$1.31K | ﹤0.01% | 2074 |
|
|
2022
Q2 | $8K | Sell |
166
-226
| -58% | -$10.9K | ﹤0.01% | 2217 |
|
|
2022
Q1 | $28K | Buy |
392
+182
| +87% | +$13K | ﹤0.01% | 1661 |
|
|
2021
Q4 | $16K | Buy |
210
+5
| +2% | +$381 | ﹤0.01% | 1872 |
|
|
2021
Q3 | $12K | Sell |
205
-14
| -6% | -$820 | ﹤0.01% | 1965 |
|
|
2021
Q2 | $10K | Buy |
219
+70
| +47% | +$3.2K | ﹤0.01% | 1970 |
|
|
2021
Q1 | $7K | Buy |
149
+41
| +38% | +$1.93K | ﹤0.01% | 2000 |
|
|
2020
Q4 | $5K | Sell |
108
-257
| -70% | -$11.9K | ﹤0.01% | 1941 |
|
|
2020
Q3 | $17K | Buy |
365
+190
| +109% | +$8.85K | ﹤0.01% | 1435 |
|
|
2020
Q2 | $9K | Buy |
175
+83
| +90% | +$4.27K | ﹤0.01% | 1594 |
|
|
2020
Q1 | $5K | Buy |
+92
| New | +$5K | ﹤0.01% | 1665 |
|